Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
TWIST1
REST API REST API
Homo sapiens
TWIST1 is differentially expressed in 243 experiments: 172 organism parts: placenta, bone marrow, ... (170 more);, 175 disease states: normal, glioblastoma, ... (173 more);, 76 cell types 404 cell lines 22 compound treatments and 63 other conditions.
Synonyms TWIST, SCS, H-twist, bHLHa38, BPES3, BPES2, ACS3
Orthologs Twist1 (Mus musculus)   Twist1 (Rattus norvegicus)   TWIST1 (2 of 2) (Danio rerio)   twist1b (Danio rerio)   twi (Drosophila melanogaster)   twist1 (Xenopus laevis)   TWIST1 (Bos taurus)   (Compare orthologs)
Gene Ontology Term DNA binding, protein binding, apoptosis, transcription, DNA-dependent, positive regulation of gene expression, negative regulation of striated muscle tissue development, protein domain specific binding, transcription from RNA polymerase II promoter, transcription factor binding, cell differentiation, positive regulation of transcription from RNA polymerase II promoter, multicellular organismal development, nucleus, muscle organ development, protein heterodimerization activity, protein homodimerization activity, negative regulation of transcription from RNA polymerase II promoter, negative regulation of cell differentiation, bHLH transcription factor binding, neuron migration, positive regulation of epithelial to mesenchymal transition, cranial suture morphogenesis, neural tube closure, in utero embryonic development, embryonic hindlimb morphogenesis, cellular response to hypoxia, negative regulation of osteoblast differentiation, negative regulation of histone acetylation, E-box binding, embryonic forelimb morphogenesis, embryonic skeletal system morphogenesis, regulation of bone mineralization, osteoblast differentiation, ossification, embryonic digit morphogenesis, positive regulation of tumor necrosis factor production, aortic valve morphogenesis, negative regulation of tumor necrosis factor production, embryonic cranial skeleton morphogenesis, positive regulation of angiogenesis, embryonic limb morphogenesis, negative regulation of skeletal muscle tissue development, eyelid development in camera-type eye, negative regulation of DNA damage response, signal transduction by p53 class mediator, positive regulation of fatty acid beta-oxidation, negative regulation of histone phosphorylation, hindlimb morphogenesis, sequence-specific DNA binding transcription factor activity, embryonic camera-type eye formation, negative regulation of sequence-specific DNA binding transcription factor activity, negative regulation of peroxisome proliferator activated receptor signaling pathway, negative regulation of molecular function, sequence-specific DNA binding RNA polymerase II transcription factor activity, positive regulation of cell motility, negative regulation of oxidative phosphorylation uncoupler activity, mitral valve morphogenesis, positive regulation of monocyte chemotactic protein-1 production, negative regulation of phosphatidylinositol 3-kinase cascade, positive regulation of transcription regulatory region DNA binding
InterPro Term HLH_DNA-bd
UniProt Accession Q15672
Gene-Disease Assocation ROBINOW-SORAUF SYNDROME, CRANIOSYNOSTOSIS, TYPE 1; CRS1, SAETHRE-CHOTZEN SYNDROME; SCS
Search EB-eye ENSG00000122691
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-6573, E-GEOD-1577, E-GEOD-3526, E-MTAB-62, ... (29 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-3860, E-GEOD-17482, E-GEOD-5258, E-MEXP-1006, E-GEOD-19639, ... (40 experiments)

Factor Value U/D Experiments
LNCaP
3
E-GEOD-762, E-GEOD-14464, E-GEOD-14990
MCF-7
3
E-GEOD-19639, E-GEOD-3529, E-GEOD-20081
MDAMB175VII
2
E-MTAB-37, E-MTAB-62
A549
2
E-GEOD-6013, E-GEOD-3202
DU145
2
E-GEOD-17482, E-GEOD-20089
KG1
2
E-GEOD-24147, E-MTAB-37
398 more value(s).


Cell type

studied in E-GEOD-492, E-GEOD-20193, E-GEOD-21668, E-GEOD-19397, E-GEOD-3920, ... (40 experiments)

Factor Value U/D Experiments
induced pluripotent stem cell
2
E-GEOD-18147, E-GEOD-18265
embryonic stem cell
2
E-MEXP-930, E-GEOD-2248
endothelial cell
2
E-GEOD-3920, E-GEOD-3998
human embryonic stem cell
2
E-GEOD-20033, E-GEOD-18265
stromal cell
1
2
E-GEOD-3998, E-GEOD-1460, E-GEOD-10797
epithelial cell
1
2
E-MEXP-1327, E-GEOD-4483, E-GEOD-10797
70 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-1577, E-MEXP-1121, E-GEOD-16363, E-MTAB-62, ... (57 experiments)

Factor Value U/D Experiments
glioblastoma
4
E-GEOD-6014, E-MTAB-37, E-MTAB-62, E-GEOD-4290
Burkitt's lymphoma
3
E-MTAB-37, E-GEOD-1880, E-GEOD-96
colon carcinoma
3
E-MTAB-37, E-MTAB-62, E-GEOD-3726
lung adenocarcinoma
2
E-MTAB-62, E-GEOD-2514
neuroblastoma
2
E-MTAB-62, E-MTAB-37
obesity
2
E-MTAB-62, E-GEOD-2508
169 more value(s).


Compound treatment

studied in E-GEOD-1615, E-GEOD-15205, E-GEOD-3356, E-GEOD-5824, E-TABM-868, ... (16 experiments)

Factor Value U/D Experiments
lipopolysaccharide
2
E-MEXP-1958, E-TABM-868
valproic acid
1
E-GEOD-1615
nebivolol
1
E-GEOD-3356
DMSO
1
E-MEXP-1561
AMP
1
E-MEXP-2285
TGF
1
E-GEOD-15205
16 more value(s).


Biopsy tissue

studied in E-GEOD-5851

Factor Value U/D Experiments
liver
1
E-GEOD-5851


BioSourceProvider
studied in E-GEOD-19519

Blood/non-blood meta-groups
studied in E-MTAB-62

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Chromosomal aberration
studied in E-TABM-125, E-GEOD-1729

Clinical history
studied in E-TABM-234, E-GEOD-19743, E-TABM-125, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-MEXP-1251, E-GEOD-21589, ... (6 experiments)

Clinical treatment
studied in E-GEOD-1743, E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-5999, E-GEOD-20033, E-GEOD-3140, E-MEXP-2359, E-MTAB-62 ... (5 experiments)

dfs time (months)
studied in E-GEOD-21653

Disease stage
studied in E-GEOD-7463

Disease staging
studied in E-GEOD-1323, E-GEOD-19743, E-GEOD-3325, E-GEOD-22148, E-TABM-147, ... (7 experiments)

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-16363

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-7578, E-GEOD-20847, E-MTAB-108, E-MEXP-2340, E-GEOD-2299, ... (6 experiments)

Genotype
studied in E-GEOD-1923, E-GEOD-17476, E-TABM-868, E-GEOD-18005, E-TABM-601, ... (7 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-13073, E-GEOD-5681, E-MEXP-2657, E-GEOD-12773, E-MEXP-1446, ... (9 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-TABM-276

Individual
studied in E-TABM-325, E-MEXP-1290, E-MEXP-2069, E-GEOD-1926, E-GEOD-19330, ... (20 experiments)

Infection
studied in E-GEOD-2405, E-GEOD-9723, E-GEOD-980, E-GEOD-6802

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-12662

Material type
studied in E-GEOD-9171

Media
studied in E-MEXP-765

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-7540, E-GEOD-1801, E-AFMX-1, E-GEOD-426, E-TABM-84 ... (5 experiments)

Organism status
studied in E-GEOD-19188

Performer
studied in E-LGCL-5

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-7819, E-GEOD-21750, E-GEOD-17636

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-3254, E-GEOD-21837, E-GEOD-19445, E-GEOD-19246, E-GEOD-1343 ... (5 experiments)

Qpcr egfr dct
studied in E-GEOD-5851

Qrt pcr areg dct
studied in E-GEOD-5851

RNAi
studied in E-MEXP-101, E-GEOD-3697, E-MEXP-1857

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743

Sex
studied in E-GEOD-19069, E-GEOD-7307

Stimulation
studied in E-GEOD-20114

Strain or line
studied in E-TABM-125

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-19188

Tissue
studied in E-GEOD-30573

Translocation cyclin group
studied in E-GEOD-2912

Treatment
studied in E-GEOD-19246

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290, E-TABM-147

Tumor size
studied in E-GEOD-3494

Processing time: 0.477 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM